ArticlePharmaceuticals (Basel, Switzerland)2026
Thymoquinone Potentiates Docetaxel-Induced Antitumor Activity with the Involvement of ROS and PI3K/AKT Pathway Modulation in Triple-Negative Breast Cancer Cells.
Aylin Orhaner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.